Although direct clinical evidence of systemic NAD(P) depletion during GLP-1RA therapy is lacking, experimental and observational studies suggest that NAD turnover and micronutrient status can be altered in obesity and inflammatory states [83, 85], supporting the biological plausibility of substrate-sensitive vulnerability
When vomiting or diarrhea occurs, the body loses not only water but also electrolytes, triggering compensatory mechanisms including increased thirst
PlexusDx has no affiliate deal, sponsorship, or commercial relationship with Hers, Fridays, or their parent companies
Typical plateau timing and duration Most patients experience their first significant plateau somewhere between months three and six
Potential Application Beyond Weight Loss There is some therapeutic potential for GLP-1 receptor agonists beyond weight loss, with early research showing promising implications for treating various metabolic and cardiovascular conditions
4 In some categories, the decline was even steeper: Household spending on salty snacks fell by 24%, for instance, and sweet bakery purchases dropped 18%